PSNL
Personalis, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$17.20
+2.20%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 20.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.81x
- Price / sales
- 26.37x
- Price / cash flow
- -19.90x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 23.86x
- EV / EBITDA
- -17.10x
- EV / EBIT
- -14.54x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026